Overview

Mild To Moderate Erectile Dysfunction Study

Status:
Completed
Trial end date:
2006-02-01
Target enrollment:
Participant gender:
Summary
Safety/Efficacy of 100-mg Viagra at 8 hours post dose in men with mild to moderate erectile dysfunction
Phase:
Phase 4
Details
Lead Sponsor:
Pfizer
Pfizer's Upjohn has merged with Mylan to form Viatris Inc.
Treatments:
Sildenafil Citrate